Tags: Drug.

Anagliptin (INN; trade name Suiny) is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It is approved for use in Japan. It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase-4 inhibitors or gliptins.

Anagliptin.svg
ATC prefix
none
CAS number
739366-20-2
IUPAC name
N-[2-[[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]-2-methylpyrazolo[15-a]pyrimidine-6-carboxamide

Loading...

This page contains content from the copyrighted Wikipedia article "Anagliptin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.